MedPath

Evaluating Midazolam effect on post ECT complications in teenagers

Phase 3
Recruiting
Conditions
electroconvulsive therapy complications.
Registration Number
IRCT20160307026950N16
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
69
Inclusion Criteria

13 to 18 years of age
ASA I&II
Having indications for ECT
Written consent from parents
NPO regimen

Exclusion Criteria

Patients who do not have a stable Hemodynamic status
Patients with major diseases like asthma, drug allergy, neuromuscular diseases ,epilepsy, hypertension and cardiovascular diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath